These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12796756)

  • 1. Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era.
    Ghazzal Z; Ashfaq S; Morris DC; Douglas JS; Marshall JJ; King SB; Weintraub WS
    Am Heart J; 2003 Jun; 145(6):1006-12. PubMed ID: 12796756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.
    Prasad A; Rihal CS; Lennon RJ; Singh M; Jaffe AS; Holmes DR
    Circ Cardiovasc Interv; 2008 Aug; 1(1):10-9. PubMed ID: 20031650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
    Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality.
    Prasad A; Singh M; Lerman A; Lennon RJ; Holmes DR; Rihal CS
    J Am Coll Cardiol; 2006 Nov; 48(9):1765-70. PubMed ID: 17084247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations.
    Miller WL; Garratt KN; Burritt MF; Lennon RJ; Reeder GS; Jaffe AS
    Eur Heart J; 2006 May; 27(9):1061-9. PubMed ID: 16481332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential release of cardiac enzymes after percutaneous coronary intervention.
    Matthews MA; Kunselman SJ; Gascho JA; Gilchrist IC
    Catheter Cardiovasc Interv; 2005 May; 65(1):19-24. PubMed ID: 15812827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
    Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
    Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes.
    Karha J; Gurm HS; Rajagopal V; Fathi R; Bavry AA; Brener SJ; Lincoff AM; Ellis SG; Bhatt DL
    Am J Cardiol; 2006 Oct; 98(7):906-10. PubMed ID: 16996871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction.
    Halkin A; Stone GW; Grines CL; Cox DA; Rutherford BD; Esente P; Meils CM; Albertsson P; Farah A; Tcheng JE; Lansky AJ; Mehran R
    J Am Coll Cardiol; 2006 Mar; 47(5):951-61. PubMed ID: 16516077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
    Coron Artery Dis; 2009 Jan; 20(1):9-14. PubMed ID: 19050596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic importance of troponin T and creatine kinase after elective angioplasty.
    Nienhuis MB; Ottervanger JP; Dikkeschei B; Suryapranata H; de Boer MJ; Dambrink JH; Hoorntje JC; van 't Hof AW; Gosselink M; Zijlstra F
    Int J Cardiol; 2007 Aug; 120(2):242-7. PubMed ID: 17182137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
    Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
    Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
    J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Gasior M; Stasik-Pres G; Pres D; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; PoloĊ„ski L
    Kardiol Pol; 2007 Sep; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.
    Mehta RH; Honeycutt E; Peterson ED; Granger CB; Halabi AR; Shaw LK; Smith PK; Califf RM; Harrington RA; Sketch MH
    Circulation; 2006 Jul; 114(1 Suppl):I396-401. PubMed ID: 16820607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction.
    Chen LY; Lennon RJ; Grantham JA; Berger PB; Mathew V; Singh M; Holmes DR; Rihal CS
    Am J Cardiol; 2005 Feb; 95(3):349-54. PubMed ID: 15670543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.